Electromed (ELMD) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.07% |
| Dec 31, 2025 | 35.23% |
| Sep 30, 2025 | -27.12% |
| Jun 30, 2025 | 24.62% |
| Mar 31, 2025 | 18.47% |
| Dec 31, 2024 | 17.71% |
| Sep 30, 2024 | 29.70% |
| Jun 30, 2024 | 25.92% |
| Mar 31, 2024 | 30.91% |
| Dec 31, 2023 | 46.31% |
| Sep 30, 2023 | -22.92% |
| Jun 30, 2023 | 11.86% |
| Mar 31, 2023 | 13.56% |
| Dec 31, 2022 | 2.57% |
| Sep 30, 2022 | -48.26% |
| Jun 30, 2022 | -31.41% |
| Mar 31, 2022 | -27.00% |
| Dec 31, 2021 | -17.83% |
| Sep 30, 2021 | 13.88% |
| Jun 30, 2021 | 8.68% |
| Mar 31, 2021 | 10.60% |
| Dec 31, 2020 | -4.80% |
| Sep 30, 2020 | 21.42% |
| Jun 30, 2020 | 6.21% |
| Mar 31, 2020 | 11.87% |
| Dec 31, 2019 | 30.43% |
| Sep 30, 2019 | -8.00% |
| Jun 30, 2019 | 6.25% |
| Mar 31, 2019 | 38.77% |
| Dec 31, 2018 | 5.83% |
| Sep 30, 2018 | -16.41% |
| Jun 30, 2018 | -8.44% |
| Mar 31, 2018 | 29.29% |
| Dec 31, 2017 | 2.00% |
| Sep 30, 2017 | 23.54% |
| Jun 30, 2017 | -5.37% |
| Mar 31, 2017 | 48.56% |
| Dec 31, 2016 | 30.38% |
| Sep 30, 2016 | -8.12% |
| Jun 30, 2016 | 40.92% |
| Mar 31, 2016 | 19.96% |
| Dec 31, 2015 | 47.13% |
| Sep 30, 2015 | 47.98% |